<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33158177</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2413</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9112413</ELocationID><Abstract><AbstractText>Over the past 20 years, there has been a drastically increased understanding of the genetic basis of Amyotrophic Lateral Sclerosis. Despite the identification of more than 40 different ALS-causing mutations, the accumulation of neurotoxic misfolded proteins, inclusions, and aggregates within motor neurons is the main pathological hallmark in all cases of ALS. These protein aggregates are proposed to disrupt cellular processes and ultimately result in neurodegeneration. One of the main reasons implicated in the accumulation of protein aggregates may be defective autophagy, a highly conserved intracellular "clearance" system delivering misfolded proteins, aggregates, and damaged organelles to lysosomes for degradation. Autophagy is one of the primary stress response mechanisms activated in highly sensitive and specialised neurons following insult to ensure their survival. The upregulation of autophagy through pharmacological autophagy-inducing agents has largely been shown to reduce intracellular protein aggregate levels and disease phenotypes in different in vitro and in vivo models of neurodegenerative diseases. In this review, we explore the intriguing interface between ALS and autophagy, provide a most comprehensive summary of autophagy-targeted drugs that have been examined or are being developed as potential treatments for ALS to date, and discuss potential therapeutic strategies for targeting autophagy in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amin</LastName><ForeName>Azin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>Nirma D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beart</LastName><ForeName>Philip M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Bradley J</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0001-6580-7655</Identifier><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shabanpoor</LastName><ForeName>Fazel</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3052, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D031204" MajorTopicYN="N">Caloric Restriction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058990" MajorTopicYN="Y">Molecular Targeted Therapy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">therapeutics</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>7</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33158177</ArticleId><ArticleId IdType="pmc">PMC7694295</ArticleId><ArticleId IdType="doi">10.3390/cells9112413</ArticleId><ArticleId IdType="pii">cells9112413</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>B&#xe4;umer D., Talbot K., Turner M.R. Advances in motor neurone disease. J. R. Soc. Med. 2014;107:14&#x2013;21. doi: 10.1177/0141076813511451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0141076813511451</ArticleId><ArticleId IdType="pmc">PMC3883149</ArticleId><ArticleId IdType="pubmed">24399773</ArticleId></ArticleIdList></Reference><Reference><Citation>Salameh J.S., Brown R.H., Jr., Berry J.D. Amyotrophic lateral sclerosis. Semin. Neurol. 2015;35:469&#x2013;476. doi: 10.1055/s-0035-1558984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1558984</ArticleId><ArticleId IdType="pubmed">26502769</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H. Amyotrophic Lateral Sclerosis: A Guide for Patients and Families. 3rd ed. Demos Medical Publishing; New York, NY, USA: 2009.</Citation></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder D.W., Kurland L., Offord K., Beard C. Familial adult motor neuron disease: Amyotrophic lateral sclerosis. Neurology. 1986;36:511&#x2013;517. doi: 10.1212/WNL.36.4.511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.36.4.511</ArticleId><ArticleId IdType="pubmed">3960325</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokelainen M. Amyotrophic lateral sclerosis in Finland: II: Clinical characteristics. Acta Neurol. Scand. 1977;56:194&#x2013;204. doi: 10.1111/j.1600-0404.1977.tb01425.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1977.tb01425.x</ArticleId><ArticleId IdType="pubmed">906794</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M., Bede P., Montuschi A., Pender N., Chio A., Hardiman O. Predicting prognosis in amyotrophic lateral sclerosis: A simple algorithm. J. Neurol. 2015;262:1447&#x2013;1454. doi: 10.1007/s00415-015-7731-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7731-6</ArticleId><ArticleId IdType="pmc">PMC4469087</ArticleId><ArticleId IdType="pubmed">25860344</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B.G., Consortium E. Prognostic factors in ALS: A critical review. Amyotroph. Lateral. Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.-X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., Van Swieten J.C., Myllykangas L. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D., Leclerc A., Tamrazian E., Vanderburg C., Russ C., Davis A., Gilchrist J., Kasarskis E., Munsat T. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M., Brown R.H. Genetics of amyotrophic lateral sclerosis. Cold Spring Harb. Perspect. Med. 2018;8:a024125. doi: 10.1101/cshperspect.a024125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024125</ArticleId><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh P., Whitwell H., Garofalo O., Buller J., Swash M., Martin J., Gallo J.-M., Weller R., Anderton B. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis: Morphology, distribution, and specificity. Brain. 1991;114:775&#x2013;788. doi: 10.1093/brain/114.2.775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/114.2.775</ArticleId><ArticleId IdType="pubmed">1646064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y., Amari M., Takatama M., Aizawa H., Mihara B., Okamoto K. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2006;249:13&#x2013;18. doi: 10.1016/j.jns.2006.05.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.05.060</ArticleId><ArticleId IdType="pubmed">16820172</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Arai K., Del Tredici K., Toledo J.B., Robinson J.L., Lee E.B., Kuwabara S., Shibuya K., Irwin D.J., Fang L. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423&#x2013;437. doi: 10.1007/s00401-014-1299-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1299-6</ArticleId><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller K.J., Cheung C.J., Restrepo C.R., Kwong L.K., Stieber A.M., Trojanowski J.Q., Lee V.M.-Y. Selective motor neuron resistance and recovery in a new inducible mouse model of TDP-43 proteinopathy. J. Neurosci. 2016;36:7707&#x2013;7717. doi: 10.1523/JNEUROSCI.1457-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1457-16.2016</ArticleId><ArticleId IdType="pmc">PMC6705561</ArticleId><ArticleId IdType="pubmed">27445147</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston J.A., Ward C.L., Kopito R.R. Aggresomes: A cellular response to misfolded proteins. J. Cell Biol. 1998;143:1883&#x2013;1898. doi: 10.1083/jcb.143.7.1883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.143.7.1883</ArticleId><ArticleId IdType="pmc">PMC2175217</ArticleId><ArticleId IdType="pubmed">9864362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N., Ratti A., Silani V. Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage. CNS Neurol. Disord. Drug Targets. 2010;9:285&#x2013;296. doi: 10.2174/187152710791292585.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152710791292585</ArticleId><ArticleId IdType="pubmed">20406182</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006;75:333&#x2013;366. doi: 10.1146/annurev.biochem.75.101304.123901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.75.101304.123901</ArticleId><ArticleId IdType="pubmed">16756495</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C., Estrada L., Castilla J. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci. 2006;31:150&#x2013;155. doi: 10.1016/j.tibs.2006.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2006.01.002</ArticleId><ArticleId IdType="pubmed">16473510</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett J.T., Lansbury P.T., Jr. Seeding &#x201c;one-dimensional crystallization&#x201d; of amyloid: A pathogenic mechanism in Alzheimer&#x2019;s disease and scrapie? Cell. 1993;73:1055&#x2013;1058. doi: 10.1016/0092-8674(93)90635-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90635-4</ArticleId><ArticleId IdType="pubmed">8513491</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster J., Funke S.A. Methods for the specific detection and quantitation of amyloid-&#x3b2; oligomers in cerebrospinal fluid. J. Alzheimers Dis. 2016;53:53&#x2013;67. doi: 10.3233/JAD-151029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-151029</ArticleId><ArticleId IdType="pubmed">27163804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman R.J., Xiong C., Benzinger T.L., Fagan A.M., Goate A., Fox N.C., Marcus D.S., Cairns N.J., Xie X., Blazey T.M. Clinical and biomarker changes in dominantly inherited Alzheimer&#x2019;s disease. N. Engl. J. Med. 2012;367:795&#x2013;804. doi: 10.1056/NEJMoa1202753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1202753</ArticleId><ArticleId IdType="pmc">PMC3474597</ArticleId><ArticleId IdType="pubmed">22784036</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 2002;416:507&#x2013;511. doi: 10.1038/416507a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/416507a</ArticleId><ArticleId IdType="pubmed">11932737</ArticleId></ArticleIdList></Reference><Reference><Citation>Campioni S., Mannini B., Zampagni M., Pensalfini A., Parrini C., Evangelisti E., Relini A., Stefani M., Dobson C.M., Cecchi C. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat. Chem. Biol. 2010;6:140&#x2013;147. doi: 10.1038/nchembio.283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.283</ArticleId><ArticleId IdType="pubmed">20081829</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefani M., Dobson C.M. Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 2003;81:678&#x2013;699. doi: 10.1007/s00109-003-0464-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-003-0464-5</ArticleId><ArticleId IdType="pubmed">12942175</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Retzlaff M., Roos T., Frydman J. Cellular strategies of protein quality control. Cold Spring Harb. Perspect. Biol. 2011;3:a004374. doi: 10.1101/cshperspect.a004374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a004374</ArticleId><ArticleId IdType="pmc">PMC3140689</ArticleId><ArticleId IdType="pubmed">21746797</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinemeyer W., Ramos P., Dohmen R. Ubiquitin-proteasome system. Cell Mol. Life Sci. 2004;61:1562&#x2013;1578. doi: 10.1007/s00018-004-4130-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-004-4130-z</ArticleId><ArticleId IdType="pubmed">15224181</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Agar J.N., Taylor D.M., Minotti S., Durham H.D. Focal dysfunction of the proteasome: A pathogenic factor in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2004;89:1325&#x2013;1335. doi: 10.1111/j.1471-4159.2004.02453.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02453.x</ArticleId><ArticleId IdType="pubmed">15189335</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheroni C., Peviani M., Cascio P., Debiasi S., Monti C., Bendotti C. Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. Neurobiol. Dis. 2005;18:509&#x2013;522. doi: 10.1016/j.nbd.2004.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2004.12.007</ArticleId><ArticleId IdType="pubmed">15755678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheroni C., Marino M., Tortarolo M., Veglianese P., De Biasi S., Fontana E., Zuccarello L.V., Maynard C.J., Dantuma N.P., Bendotti C. Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 2009;18:82&#x2013;96. doi: 10.1093/hmg/ddn319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn319</ArticleId><ArticleId IdType="pmc">PMC3298865</ArticleId><ArticleId IdType="pubmed">18826962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Agar J.N., Hong Y., Taylor D.M., Minotti S., Figlewicz D.A., Durham H.D. Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2008;105:2353&#x2013;2366. doi: 10.1111/j.1471-4159.2008.05317.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05317.x</ArticleId><ArticleId IdType="pubmed">18315558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Agar J.N., Strong M.J., Durham H.D. Impaired proteasome function in sporadic amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. 2012;13:367&#x2013;371. doi: 10.3109/17482968.2012.686511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.686511</ArticleId><ArticleId IdType="pubmed">22632443</ArticleId></ArticleIdList></Reference><Reference><Citation>Frake R.A., Ricketts T., Menzies F.M., Rubinsztein D.C. Autophagy and neurodegeneration. J. Clin. Investig. 2015;125:65&#x2013;74. doi: 10.1172/JCI73944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI73944</ArticleId><ArticleId IdType="pmc">PMC4382230</ArticleId><ArticleId IdType="pubmed">25654552</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N. Autophagy: Process and function. Genes Dev. 2007;21:2861&#x2013;2873. doi: 10.1101/gad.1599207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1599207</ArticleId><ArticleId IdType="pubmed">18006683</ArticleId></ArticleIdList></Reference><Reference><Citation>Galbiati M., Crippa V., Rusmini P., Cristofani R., Cicardi M.E., Giorgetti E., Onesto E., Messi E., Poletti A. ALS-related misfolded protein management in motor neurons and muscle cells. Neurochem. Int. 2014;79:70&#x2013;78. doi: 10.1016/j.neuint.2014.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2014.10.007</ArticleId><ArticleId IdType="pubmed">25451799</ArticleId></ArticleIdList></Reference><Reference><Citation>Carra S., Crippa V., Rusmini P., Boncoraglio A., Minoia M., Giorgetti E., Kampinga H.H., Poletti A. Alteration of protein folding and degradation in motor neuron diseases: Implications and protective functions of small heat shock proteins. Prog. Neurobiol. 2012;97:83&#x2013;100. doi: 10.1016/j.pneurobio.2011.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.09.009</ArticleId><ArticleId IdType="pubmed">21971574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur J., Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat. Rev. Mol. Cell Biol. 2015;16:461&#x2013;472. doi: 10.1038/nrm4024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm4024</ArticleId><ArticleId IdType="pubmed">26177004</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717&#x2013;1721. doi: 10.1126/science.290.5497.1717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.290.5497.1717</ArticleId><ArticleId IdType="pmc">PMC2732363</ArticleId><ArticleId IdType="pubmed">11099404</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N., Komatsu M. Autophagy: Renovation of cells and tissues. Cell. 2011;147:728&#x2013;741. doi: 10.1016/j.cell.2011.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.10.026</ArticleId><ArticleId IdType="pubmed">22078875</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature. 2011;469:323&#x2013;335. doi: 10.1038/nature09782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09782</ArticleId><ArticleId IdType="pmc">PMC3131688</ArticleId><ArticleId IdType="pubmed">21248839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.H., Lee M.-S. Autophagy&#x2014;A key player in cellular and body metabolism. Nat. Rev. Endocrinol. 2014;10:322&#x2013;337. doi: 10.1038/nrendo.2014.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2014.35</ArticleId><ArticleId IdType="pubmed">24663220</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Z., Pascual C., Klionsky D.J. Autophagy: Machinery and regulation. Microbial Cell. 2016;3:588&#x2013;596. doi: 10.15698/mic2016.12.546.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/mic2016.12.546</ArticleId><ArticleId IdType="pmc">PMC5348978</ArticleId><ArticleId IdType="pubmed">28357331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., Jimenez-Sanchez M., Korolchuk V.I., Lichtenberg M., Luo S. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 2010;90:1383&#x2013;1435. doi: 10.1152/physrev.00030.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00030.2009</ArticleId><ArticleId IdType="pubmed">20959619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N., Levine B. Autophagy in mammalian development and differentiation. Nat. Cell Biol. 2010;12:823&#x2013;830. doi: 10.1038/ncb0910-823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb0910-823</ArticleId><ArticleId IdType="pmc">PMC3127249</ArticleId><ArticleId IdType="pubmed">20811354</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Ren X., Hait W.N., Yang J.-M. Therapeutic targeting of autophagy in disease: Biology and pharmacology. Pharmacol. Rev. 2013;65:1162&#x2013;1197. doi: 10.1124/pr.112.007120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.112.007120</ArticleId><ArticleId IdType="pmc">PMC3799234</ArticleId><ArticleId IdType="pubmed">23943849</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroemer G., Mari&#xf1;o G., Levine B. Autophagy and the integrated stress response. Mol. Cell. 2010;40:280&#x2013;293. doi: 10.1016/j.molcel.2010.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.09.023</ArticleId><ArticleId IdType="pmc">PMC3127250</ArticleId><ArticleId IdType="pubmed">20965422</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441:885&#x2013;889. doi: 10.1038/nature04724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04724</ArticleId><ArticleId IdType="pubmed">16625204</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M., Waguri S., Chiba T., Murata S., Iwata J.-I., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441:880&#x2013;884. doi: 10.1038/nature04723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04723</ArticleId><ArticleId IdType="pubmed">16625205</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M., Wang Q.J., Holstein G.R., Friedrich V.L., Iwata J.-i., Kominami E., Chait B.T., Tanaka K., Yue Z. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc. Natl. Acad. Sci. USA. 2007;104:14489&#x2013;14494. doi: 10.1073/pnas.0701311104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0701311104</ArticleId><ArticleId IdType="pmc">PMC1964831</ArticleId><ArticleId IdType="pubmed">17726112</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q.J., Ding Y., Kohtz S., Mizushima N., Cristea I.M., Rout M.P., Chait B.T., Zhong Y., Heintz N., Yue Z. Induction of autophagy in axonal dystrophy and degeneration. J. Neurosci. 2006;26:8057&#x2013;8068. doi: 10.1523/JNEUROSCI.2261-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2261-06.2006</ArticleId><ArticleId IdType="pmc">PMC6673783</ArticleId><ArticleId IdType="pubmed">16885219</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinsztein D.C., DiFiglia M., Heintz N., Nixon R.A., Qin Z.-H., Ravikumar B., Stefanis L., Tolkovsky A. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy. 2005;1:11&#x2013;22. doi: 10.4161/auto.1.1.1513.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.1.1.1513</ArticleId><ArticleId IdType="pubmed">16874045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Kundu M., Viollet B., Guan K.-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011;13:132&#x2013;141. doi: 10.1038/ncb2152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2152</ArticleId><ArticleId IdType="pmc">PMC3987946</ArticleId><ArticleId IdType="pubmed">21258367</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung C.H., Jun C.B., Ro S.-H., Kim Y.-M., Otto N.M., Cao J., Kundu M., Kim D.-H. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell. 2009;20:1992&#x2013;2003. doi: 10.1091/mbc.e08-12-1249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e08-12-1249</ArticleId><ArticleId IdType="pmc">PMC2663920</ArticleId><ArticleId IdType="pubmed">19225151</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganley I.G., Lam D.H., Wang J., Ding X., Chen S., Jiang X. ULK1&#xb7;ATG13&#xb7;FIP200 complex mediates mTOR signaling and is essential for autophagy. J. Biol. Chem. 2009;284:12297&#x2013;12305. doi: 10.1074/jbc.M900573200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M900573200</ArticleId><ArticleId IdType="pmc">PMC2673298</ArticleId><ArticleId IdType="pubmed">19258318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth M., Joachim J., Tooze S.A. Seminars in Cancer Biology. Volume 23. Academic Press; Cambridge, MA, USA: 2013. Autophagosome formation&#x2014;The role of ULK1 and Beclin1&#x2013;PI3KC3 complexes in setting the stage; pp. 301&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">23727157</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y., Wang Q.J., Li X., Yan Y., Backer J.M., Chait B.T., Heintz N., Yue Z. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1&#x2013;phosphatidylinositol-3-kinase complex. Nat. Cell Biol. 2009;11:468&#x2013;476. doi: 10.1038/ncb1854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1854</ArticleId><ArticleId IdType="pmc">PMC2664389</ArticleId><ArticleId IdType="pubmed">19270693</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell R.C., Tian Y., Yuan H., Park H.W., Chang Y.-Y., Kim J., Kim H., Neufeld T.P., Dillin A., Guan K.-L. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat. Cell Biol. 2013;15:741&#x2013;750. doi: 10.1038/ncb2757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2757</ArticleId><ArticleId IdType="pmc">PMC3885611</ArticleId><ArticleId IdType="pubmed">23685627</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts R., Ktistakis N.T. Omegasomes: PI3P platforms that manufacture autophagosomes. Essays Biochem. 2013;55:17&#x2013;27. doi: 10.1042/bse0550017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bse0550017</ArticleId><ArticleId IdType="pubmed">24070468</ArticleId></ArticleIdList></Reference><Reference><Citation>Polson H.E., de Lartigue J., Rigden D.J., Reedijk M., Urb&#xe9; S., Clague M.J., Tooze S.A. Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy. 2010;6:506&#x2013;522. doi: 10.4161/auto.6.4.11863.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.6.4.11863</ArticleId><ArticleId IdType="pubmed">20505359</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolz A., Ernst A., Dikic I. Cargo recognition and trafficking in selective autophagy. Nat. Cell Biol. 2014;16:495&#x2013;501. doi: 10.1038/ncb2979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2979</ArticleId><ArticleId IdType="pubmed">24875736</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda N.N., Kumeta H., Nakatogawa H., Satoo K., Adachi W., Ishii J., Fujioka Y., Ohsumi Y., Inagaki F. Structural basis of target recognition by Atg8/LC3 during selective autophagy. Genes Cells. 2008;13:1211&#x2013;1218. doi: 10.1111/j.1365-2443.2008.01238.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2443.2008.01238.x</ArticleId><ArticleId IdType="pubmed">19021777</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf8;rk&#xf8;y G., Lamark T., Pankiv S., &#xd8;vervatn A., Brech A., Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 2009;452:181&#x2013;197. doi: 10.1016/S0076-6879(08)03612-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(08)03612-4</ArticleId><ArticleId IdType="pubmed">19200883</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanov J., Walczak M., Ibiricu I., Sch&#xfc;chner S., Ogris E., Kraft C., Martens S. Mechanism and functions of membrane binding by the Atg5&#x2013;Atg12/Atg16 complex during autophagosome formation. EMBO J. 2012;31:4304&#x2013;4317. doi: 10.1038/emboj.2012.278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.278</ArticleId><ArticleId IdType="pmc">PMC3501226</ArticleId><ArticleId IdType="pubmed">23064152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichimura Y., Kirisako T., Takao T., Satomi Y., Shimonishi Y., Ishihara N., Mizushima N., Tanida I., Kominami E., Ohsumi M. A ubiquitin-like system mediates protein lipidation. Nature. 2000;408:488&#x2013;492. doi: 10.1038/35044114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35044114</ArticleId><ArticleId IdType="pubmed">11100732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabeya Y., Mizushima N., Yamamoto A., Oshitani-Okamoto S., Ohsumi Y., Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 2004;117:2805&#x2013;2812. doi: 10.1242/jcs.01131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01131</ArticleId><ArticleId IdType="pubmed">15169837</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatogawa H., Ichimura Y., Ohsumi Y. Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion. Cell. 2007;130:165&#x2013;178. doi: 10.1016/j.cell.2007.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.05.021</ArticleId><ArticleId IdType="pubmed">17632063</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z.-Q., Ni T., Hong B., Wang H.-Y., Jiang F.-J., Zou S., Chen Y., Zheng X.-L., Klionsky D.J., Liang Y. Dual roles of Atg8&#x2212; PE deconjugation by Atg4 in autophagy. Autophagy. 2012;8:883&#x2013;892. doi: 10.4161/auto.19652.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.19652</ArticleId><ArticleId IdType="pmc">PMC3427254</ArticleId><ArticleId IdType="pubmed">22652539</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura S., Noda T., Yoshimori T. Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. Cell Struct. Funct. 2008;33:109&#x2013;122. doi: 10.1247/csf.08005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1247/csf.08005</ArticleId><ArticleId IdType="pubmed">18388399</ArticleId></ArticleIdList></Reference><Reference><Citation>Itakura E., Kishi-Itakura C., Mizushima N. The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell. 2012;151:1256&#x2013;1269. doi: 10.1016/j.cell.2012.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.11.001</ArticleId><ArticleId IdType="pubmed">23217709</ArticleId></ArticleIdList></Reference><Reference><Citation>Metcalf D., Isaacs A.M. The role of ESCRT proteins in fusion events involving lysosomes, endosomes and autophagosomes. Biochem. Soc. Trans. 2010;38:1469&#x2013;1473. doi: 10.1042/BST0381469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0381469</ArticleId><ArticleId IdType="pubmed">21118109</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvezin C., Nagy P., Juh&#xe1;sz G., Neufeld T.P. Autophagosome&#x2013;lysosome fusion is independent of V-ATPase-mediated acidification. Nat. Commun. 2015;6:7007&#x2013;7021. doi: 10.1038/ncomms8007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8007</ArticleId><ArticleId IdType="pmc">PMC4428688</ArticleId><ArticleId IdType="pubmed">25959678</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison R.E., Bucci C., Vieira O.V., Schroer T.A., Grinstein S. Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: Role of Rab7 and RILP. Mol. Cell Biol. 2003;23:6494&#x2013;6506. doi: 10.1128/MCB.23.18.6494-6506.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.23.18.6494-6506.2003</ArticleId><ArticleId IdType="pmc">PMC193691</ArticleId><ArticleId IdType="pubmed">12944476</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiv S., Alemu E.A., Brech A., Bruun J.-A., Lamark T., &#xd8;vervatn A., Bj&#xf8;rk&#xf8;y G., Johansen T. FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end&#x2013;directed vesicle transport. J. Cell Biol. 2010;188:253&#x2013;269. doi: 10.1083/jcb.200907015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200907015</ArticleId><ArticleId IdType="pmc">PMC2812517</ArticleId><ArticleId IdType="pubmed">20100911</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;ger S., Bucci C., Tanida I., Ueno T., Kominami E., Saftig P., Eskelinen E.-L. Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci. 2004;117:4837&#x2013;4848. doi: 10.1242/jcs.01370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01370</ArticleId><ArticleId IdType="pubmed">15340014</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancak Y., Bar-Peled L., Zoncu R., Markhard A.L., Nada S., Sabatini D.M. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell. 2010;141:290&#x2013;303. doi: 10.1016/j.cell.2010.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.02.024</ArticleId><ArticleId IdType="pmc">PMC3024592</ArticleId><ArticleId IdType="pubmed">20381137</ArticleId></ArticleIdList></Reference><Reference><Citation>Korolchuk V.I., Saiki S., Lichtenberg M., Siddiqi F.H., Roberts E.A., Imarisio S., Jahreiss L., Sarkar S., Futter M., Menzies F.M. Lysosomal positioning coordinates cellular nutrient responses. Nat. Cell Biol. 2011;13:453&#x2013;460. doi: 10.1038/ncb2204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2204</ArticleId><ArticleId IdType="pmc">PMC3071334</ArticleId><ArticleId IdType="pubmed">21394080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoncu R., Bar-Peled L., Efeyan A., Wang S., Sancak Y., Sabatini D.M. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H+-ATPase. Science. 2011;334:678&#x2013;683. doi: 10.1126/science.1207056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1207056</ArticleId><ArticleId IdType="pmc">PMC3211112</ArticleId><ArticleId IdType="pubmed">22053050</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.C., Holzbaur E.L. Autophagosome dynamics in neurodegeneration at a glance. J. Cell Sci. 2015;128:1259&#x2013;1267. doi: 10.1242/jcs.161216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.161216</ArticleId><ArticleId IdType="pmc">PMC4379723</ArticleId><ArticleId IdType="pubmed">25829512</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Br&#xe4;nnstr&#xf6;m T., Andersen P.M., Marklund S.L. Low autophagy capacity implicated in motor system vulnerability to mutant superoxide dismutase. Acta Neuropathol. Commun. 2016;4:6&#x2013;24. doi: 10.1186/s40478-016-0274-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0274-y</ArticleId><ArticleId IdType="pmc">PMC4727314</ArticleId><ArticleId IdType="pubmed">26810478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C., Thielen P., Matus S., Nassif M., Kiffin R., Martinez G., Cuervo A.M., Brown R.H., Glimcher L.H. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 2009;23:2294&#x2013;2306. doi: 10.1101/gad.1830709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1830709</ArticleId><ArticleId IdType="pmc">PMC2758741</ArticleId><ArticleId IdType="pubmed">19762508</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian F., Morimoto N., Liu W., Ohta Y., Deguchi K., Miyazaki K., Abe K. In vivo optical imaging of motor neuron autophagy in a mouse model of amyotrophic lateral sclerosis. Autophagy. 2011;7:985&#x2013;992. doi: 10.4161/auto.7.9.16012.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.9.16012</ArticleId><ArticleId IdType="pubmed">21628996</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Zhang X., Le W. Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy. 2008;4:290&#x2013;293. doi: 10.4161/auto.5524.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5524</ArticleId><ArticleId IdType="pubmed">18196963</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto N., Nagai M., Ohta Y., Miyazaki K., Kurata T., Morimoto M., Murakami T., Takehisa Y., Ikeda Y., Kamiya T. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007;1167:112&#x2013;117. doi: 10.1016/j.brainres.2007.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.06.045</ArticleId><ArticleId IdType="pubmed">17689501</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2011;70:349&#x2013;359. doi: 10.1097/NEN.0b013e3182160690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3182160690</ArticleId><ArticleId IdType="pubmed">21487309</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Dykes-Hoberg M., Culotta V.C., Price D.L., Wong P.C., Rothstein J.D. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 2001;8:933&#x2013;941. doi: 10.1006/nbdi.2001.0443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0443</ArticleId><ArticleId IdType="pubmed">11741389</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Iwata M. Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 1996;204:53&#x2013;56. doi: 10.1016/0304-3940(96)12314-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(96)12314-4</ArticleId><ArticleId IdType="pubmed">8929976</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsumi T. The ultrastructure of intramuscular nerves in amyotrophic lateral sclerosis. Acta Neuropathol. 1981;55:193&#x2013;198. doi: 10.1007/BF00691318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00691318</ArticleId><ArticleId IdType="pubmed">7349578</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoli L., Crugnola V., Lamperti C., Silani V., Di Mauro S., Bresolin N., Moggio M. Ultrastructural mitochondrial abnormalities in patients with sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011;68:1612&#x2013;1613. doi: 10.1001/archneur.68.12.1612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.68.12.1612</ArticleId><ArticleId IdType="pubmed">22159065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikl&#xf3;s L., Engelhardt J., Harati Y., Smith R.G., Jo&#xf3; F., Appel S.H. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophc lateral sclerosis. Ann. Neurol. 1996;39:203&#x2013;216. doi: 10.1002/ana.410390210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390210</ArticleId><ArticleId IdType="pubmed">8967752</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M.J., Suh Y.-L. Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct. Pathol. 2002;26:3&#x2013;7. doi: 10.1080/01913120252934260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01913120252934260</ArticleId><ArticleId IdType="pubmed">12028652</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann F.R., Winkler K., Kuznetsov A.V., Bartels C., Vielhaber S., Feistner H., Kunz W.S. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 1998;156:65&#x2013;72. doi: 10.1016/S0022-510X(98)00008-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00008-2</ArticleId><ArticleId IdType="pubmed">9559989</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkin J.D., Farg M.A., Walker A.K., McLean C., Tomas D., Horne M.K. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol. Dis. 2008;30:400&#x2013;407. doi: 10.1016/j.nbd.2008.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.02.009</ArticleId><ArticleId IdType="pubmed">18440237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y., Yamada M., Tanaka H., Aida K., Tsuruma K., Shimazawa M., Hozumi I., Inuzuka T., Takahashi H., Hara H. Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice. Neurobiol. Dis. 2009;36:470&#x2013;476. doi: 10.1016/j.nbd.2009.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.08.013</ArticleId><ArticleId IdType="pubmed">19733664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S. Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2010;69:346&#x2013;355. doi: 10.1097/NEN.0b013e3181d44992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181d44992</ArticleId><ArticleId IdType="pubmed">20448480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva E.V., Ayala V., Jov&#xe9; M., Dalf&#xf3; E., Cacabelos D., Povedano M., Bellmunt M.J., Ferrer I., Pamplona R., Portero-Ot&#xed;n M. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain. 2007;130:3111&#x2013;3123. doi: 10.1093/brain/awm190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm190</ArticleId><ArticleId IdType="pubmed">17716997</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Cabuy E., Caroni P. A role for motoneuron subtype&#x2013;selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 2009;12:627&#x2013;636. doi: 10.1038/nn.2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen T., Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy. 2011;7:279&#x2013;296. doi: 10.4161/auto.7.3.14487.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.3.14487</ArticleId><ArticleId IdType="pmc">PMC3060413</ArticleId><ArticleId IdType="pubmed">21189453</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujikake N., Shin M., Shimizu S. Association between autophagy and neurodegenerative diseases. Front. Neurosci. 2018;12:255. doi: 10.3389/fnins.2018.00255.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00255</ArticleId><ArticleId IdType="pmc">PMC5972210</ArticleId><ArticleId IdType="pubmed">29872373</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohli L., Roth K.A. Autophagy: Cerebral home cooking. Am. J. Pathol. 2010;176:1065&#x2013;1071. doi: 10.2353/ajpath.2010.090850.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.090850</ArticleId><ArticleId IdType="pmc">PMC2832126</ArticleId><ArticleId IdType="pubmed">20150434</ArticleId></ArticleIdList></Reference><Reference><Citation>Boya P., Gonz&#xe1;lez-Polo R.-A., Casares N., Perfettini J.-L., Dessen P., Larochette N., M&#xe9;tivier D., Meley D., Souquere S., Yoshimori T. Inhibition of macroautophagy triggers apoptosis. Mol. Cell Biol. 2005;25:1025&#x2013;1040. doi: 10.1128/MCB.25.3.1025-1040.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.25.3.1025-1040.2005</ArticleId><ArticleId IdType="pmc">PMC543994</ArticleId><ArticleId IdType="pubmed">15657430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.-A., Gao F.-B. Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional ESCRT-III in frontotemporal dementia. J. Neurosci. 2009;29:8506&#x2013;8511. doi: 10.1523/JNEUROSCI.0924-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0924-09.2009</ArticleId><ArticleId IdType="pmc">PMC2726650</ArticleId><ArticleId IdType="pubmed">19571141</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick N.D., Griffey C.J., Guarnieri P., Gerbino V., Wang X., Piersaint J.A., Tapia J.C., Rich M.M., Maniatis T. Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS. Proc. Natl. Acad. Sci. USA. 2017;114:E8294&#x2013;E8303. doi: 10.1073/pnas.1704294114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704294114</ArticleId><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q.M., Zhang J.J., Li S., Chen S., Le W.D. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD 1G93A mouse model of amyotrophic lateral sclerosis. CNS Neurosci. Ther. 2017;23:375&#x2013;385. doi: 10.1111/cns.12681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12681</ArticleId><ArticleId IdType="pmc">PMC6492644</ArticleId><ArticleId IdType="pubmed">28229532</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsueh K.-W., Chiou T.-W., Chiang S.-F., Yamashita T., Abe K., Borlongan C.V., Sanberg P.R., Lin S.-Z., Harn H.-J. Autophagic down-regulation in motor neurons remarkably prolongs the survival of ALS mice. Neuropharmacology. 2016;108:152&#x2013;160. doi: 10.1016/j.neuropharm.2016.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.03.035</ArticleId><ArticleId IdType="pubmed">27059126</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak Y.J., Park J.-H., Rhim H., Kang S. ALS-Related Mutant SOD1 Aggregates Interfere with Mitophagy by Sequestering the Autophagy Receptor Optineurin. Int. J. Mol. Sci. 2020;21:7525. doi: 10.3390/ijms21207525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21207525</ArticleId><ArticleId IdType="pmc">PMC7590160</ArticleId><ArticleId IdType="pubmed">33065963</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., Brown R.H., Jr. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43:19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A., Arbel N., Da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., Cleveland D.W. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron. 2010;67:575&#x2013;587. doi: 10.1016/j.neuron.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W., Song Y., Kincaid B., Bossy B., Bossy-Wetzel E. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1&#x3b1;. Neurobiol. Dis. 2013;51:72&#x2013;81. doi: 10.1016/j.nbd.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.07.004</ArticleId><ArticleId IdType="pmc">PMC3992938</ArticleId><ArticleId IdType="pubmed">22819776</ArticleId></ArticleIdList></Reference><Reference><Citation>Moller A., Bauer C.S., Cohen R.N., Webster C.P., De Vos K.J. Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels. Hum. Mol. Genet. 2017;26:4668&#x2013;4679. doi: 10.1093/hmg/ddx348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx348</ArticleId><ArticleId IdType="pmc">PMC5886184</ArticleId><ArticleId IdType="pubmed">28973175</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky V.N. The roles of intrinsic disorder-based liquid-liquid phase transitions in the &#x201c;Dr. Jekyll&#x2013;Mr. Hyde&#x201d; behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Autophagy. 2017;13:2115&#x2013;2162. doi: 10.1080/15548627.2017.1384889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1384889</ArticleId><ArticleId IdType="pmc">PMC5788550</ArticleId><ArticleId IdType="pubmed">28980860</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Str&#xf6;m A.-L., Fukada K., Lee S., Hayward L.J., Zhu H. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J. Biol. Chem. 2007;282:16691&#x2013;16699. doi: 10.1074/jbc.M609743200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M609743200</ArticleId><ArticleId IdType="pubmed">17403682</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D.K., Thombre R., Wang J. Autophagy as a common pathway in amyotrophic lateral sclerosis. Neurosci. Lett. 2018:34&#x2013;48. doi: 10.1016/j.neulet.2018.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.04.006</ArticleId><ArticleId IdType="pmc">PMC6170747</ArticleId><ArticleId IdType="pubmed">29626651</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif M., Valenzuela V., Rojas-Rivera D., Vidal R., Matus S., Castillo K., Fuentealba Y., Kroemer G., Levine B., Hetz C. Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy. 2014;10:1256&#x2013;1271. doi: 10.4161/auto.28784.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.28784</ArticleId><ArticleId IdType="pmc">PMC4203551</ArticleId><ArticleId IdType="pubmed">24905722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin A.M., Shadfar S., Vidal M., Jamali S., Atkin J.D. Motor neuron susceptibility in ALS/FTD. Front. Neurosci. 2019;13:532. doi: 10.3389/fnins.2019.00532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00532</ArticleId><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., Van Den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:1&#x2013;19. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Hart P.J., Borchelt D.R., Andersen P.M. Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease. Hum. Mol. Genet. 2009;18:3217&#x2013;3226. doi: 10.1093/hmg/ddp260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp260</ArticleId><ArticleId IdType="pmc">PMC2722984</ArticleId><ArticleId IdType="pubmed">19483195</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F., Stefani M., Taddei N., Ramponi G., Dobson C.M. Rationalization of the effects of mutations on peptide andprotein aggregation rates. Nature. 2003;424:805&#x2013;808. doi: 10.1038/nature01891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01891</ArticleId><ArticleId IdType="pubmed">12917692</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilloni C., Sala B.M., Sormanni P., Porcari R., Corazza A., De Rosa M., Zanini S., Barbiroli A., Esposito G., Bolognesi M. Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability. Sci. Rep. 2016;6:1&#x2013;11. doi: 10.1038/srep25559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25559</ArticleId><ArticleId IdType="pmc">PMC4858664</ArticleId><ArticleId IdType="pubmed">27150430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim N.C., Wang Y.-D., Scarborough E.A., Moore J., Diaz Z., MacLea K.S., Freibaum B., Li S., Molliex A. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Pokrishevsky E., Silverman J.M., Cashman N.R. Exosome-dependent and independent mechanisms are involved in prion-like transmission of propagated Cu/Zn superoxide dismutase misfolding. Prion. 2014;8:331&#x2013;335. doi: 10.4161/19336896.2014.983398.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/19336896.2014.983398</ArticleId><ArticleId IdType="pmc">PMC4601269</ArticleId><ArticleId IdType="pubmed">25551548</ArticleId></ArticleIdList></Reference><Reference><Citation>King O.D., Gitler A.D., Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012;1462:61&#x2013;80. doi: 10.1016/j.brainres.2012.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.01.016</ArticleId><ArticleId IdType="pmc">PMC3372647</ArticleId><ArticleId IdType="pubmed">22445064</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M., Johnson B.S., King O.D., Gitler A.D., Shorter J. Prion-like disorders: Blurring the divide between transmissibility and infectivity. J. Cell Sci. 2010;123:1191&#x2013;1201. doi: 10.1242/jcs.051672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.051672</ArticleId><ArticleId IdType="pmc">PMC2848109</ArticleId><ArticleId IdType="pubmed">20356930</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C., O&#x2019;Brien J., Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. USA. 2011;108:3548&#x2013;3553. doi: 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Cleveland D.W. The seeds of neurodegeneration: Prion-like spreading in ALS. Cell. 2011;147:498&#x2013;508. doi: 10.1016/j.cell.2011.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.10.011</ArticleId><ArticleId IdType="pmc">PMC3220614</ArticleId><ArticleId IdType="pubmed">22036560</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Guest W.C., Yanai A., Pokrishevsky E., O&#x2019;Neill M.A., Gibbs E., Semenchenko V., Yousefi M., Wishart D.S., Plotkin S.S. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc. Natl. Acad. Sci. USA. 2011;108:16398&#x2013;16403. doi: 10.1073/pnas.1102645108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M., Walker L.C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. 2013;501:45&#x2013;51. doi: 10.1038/nature12481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12481</ArticleId><ArticleId IdType="pmc">PMC3963807</ArticleId><ArticleId IdType="pubmed">24005412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J. Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis. Exp. Neurol. 2014;262:121&#x2013;126. doi: 10.1016/j.expneurol.2014.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.07.021</ArticleId><ArticleId IdType="pubmed">25108067</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Yerbury J.J., Turner B.J., Guest W.C., Pokrishevsky E., O&#x2019;Neill M.A., Yanai A., Silverman J.M., Zeineddine R., Corcoran L. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and-independent mechanisms. Proc. Natl. Acad. Sci. USA. 2014;111:3620&#x2013;3625. doi: 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata M., Lu T., Furuya T., Degterev A., Mizushima N., Yoshimori T., MacDonald M., Yankner B., Yuan J. Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J. Biol. Chem. 2006;281:14474&#x2013;14485. doi: 10.1074/jbc.M600364200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M600364200</ArticleId><ArticleId IdType="pubmed">16522639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipinski M.M., Zheng B., Lu T., Yan Z., Py B.F., Ng A., Xavier R.J., Li C., Yankner B.A., Scherzer C.R. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2010;107:14164&#x2013;14169. doi: 10.1073/pnas.1009485107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1009485107</ArticleId><ArticleId IdType="pmc">PMC2922576</ArticleId><ArticleId IdType="pubmed">20660724</ArticleId></ArticleIdList></Reference><Reference><Citation>Terman A., Gustafsson B., Brunk U. Autophagy, organelles and ageing. J. Pathol. 2007;211:134&#x2013;143. doi: 10.1002/path.2094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2094</ArticleId><ArticleId IdType="pubmed">17200947</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Vicente M., Sovak G., Cuervo A.M. Protein degradation and aging. Exp. Gerontol. 2005;40:622&#x2013;633. doi: 10.1016/j.exger.2005.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2005.07.005</ArticleId><ArticleId IdType="pubmed">16125351</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando R., Castro J.P., Flore T., Deubel S., Grune T., Ott C. Age-Related Maintenance of the Autophagy-Lysosomal System Is Dependent on Skeletal Muscle Type. Oxid. Med. Cell. Longev. 2020;2020 doi: 10.1155/2020/4908162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/4908162</ArticleId><ArticleId IdType="pmc">PMC7396090</ArticleId><ArticleId IdType="pubmed">32774673</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Lin S., Staats K.A., Li Y., Chang W.-H., Hung S.-T., Hendricks E., Linares G.R., Wang Y., Son E.Y. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo K.Y., Halloran M., Sundaramoorthy V., Parakh S., Toth R.P., Southam K.A., McLean C.A., Lock P., King A., Farg M.A. Rab1-dependent ER&#x2013;Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS. Acta Neuropathol. 2015;130:679&#x2013;697. doi: 10.1007/s00401-015-1468-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1468-2</ArticleId><ArticleId IdType="pubmed">26298469</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R., De Vos K.J., Paillusson S., Mueller S., Sancho R.M., Lau K.-F., Vizcay-Barrena G., Lin W.-L., Xu Y.-F., Lewis J. ER&#x2013;mitochondria associations are regulated by the VAPB&#x2013;PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat. Commun. 2014;5:3996&#x2013;4007. doi: 10.1038/ncomms4996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4996</ArticleId><ArticleId IdType="pmc">PMC4046113</ArticleId><ArticleId IdType="pubmed">24893131</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.-C., Sun E., Wancewicz E., Mazur C. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.-C., Liang T.Y., Mazur C. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose J.K., Huang C.C., Shen C.J. Regulation of autophagy by the neuropathological protein TDP-43. J. Biol. Chem. 2011;286:44441&#x2013;44448. doi: 10.1074/jbc.M111.237115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.237115</ArticleId><ArticleId IdType="pmc">PMC3247982</ArticleId><ArticleId IdType="pubmed">22052911</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q., Wang H., Hao Z., Fu C., Hu Q., Gao F., Ren H., Chen D., Han J., Ying Z. TDP-43 loss of function increases TFEB activity and blocks autophagosome&#x2013;lysosome fusion. EMBO J. 2016;35:121&#x2013;142. doi: 10.15252/embj.201591998.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201591998</ArticleId><ArticleId IdType="pmc">PMC4718457</ArticleId><ArticleId IdType="pubmed">26702100</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel F.C., Voigt A., Weber S.S., Van den Haute C., Waldenmaier A., G&#xf6;rner K., Walter M., Anderson M.L., Kern J.V., Rasse T.M. Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J. 2010;29:209&#x2013;221. doi: 10.1038/emboj.2009.324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2009.324</ArticleId><ArticleId IdType="pmc">PMC2808372</ArticleId><ArticleId IdType="pubmed">19910924</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.-F., Wang Q., Krueger B.J. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., M&#xfc;ller K., Marroquin N., Nordin F., H&#xfc;bers A., Weydt P. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Kanekura K., Levine T.P., Kohno K., Olkkonen V.M., Aiso S., Matsuoka M. ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J. Neurochem. 2009;108:973&#x2013;985. doi: 10.1111/j.1471-4159.2008.05857.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05857.x</ArticleId><ArticleId IdType="pubmed">19183264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Suaga P., Paillusson S., Miller C.C. ER-mitochondria signaling regulates autophagy. Autophagy. 2017;13:1250&#x2013;1251. doi: 10.1080/15548627.2017.1317913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1317913</ArticleId><ArticleId IdType="pmc">PMC5529068</ArticleId><ArticleId IdType="pubmed">28548902</ArticleId></ArticleIdList></Reference><Reference><Citation>Jantrapirom S., Piccolo L.L., Yoshida H., Yamaguchi M. Depletion of Ubiquilin induces an augmentation in soluble ubiquitinated Drosophila TDP-43 to drive neurotoxicity in the fly. Biochim. Biophys. Acta Mol. Basis Dis. 2018;1864:3038&#x2013;3049. doi: 10.1016/j.bbadis.2018.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2018.06.017</ArticleId><ArticleId IdType="pubmed">29936333</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothenberg C., Srinivasan D., Mah L., Kaushik S., Peterhoff C.M., Ugolino J., Fang S., Cuervo A.M., Nixon R.A., Monteiro M.J. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum. Mol. Genet. 2010;19:3219&#x2013;3232. doi: 10.1093/hmg/ddq231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq231</ArticleId><ArticleId IdType="pmc">PMC2908472</ArticleId><ArticleId IdType="pubmed">20529957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju J.-S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009;187:875&#x2013;888. doi: 10.1083/jcb.200908115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908115</ArticleId><ArticleId IdType="pmc">PMC2806317</ArticleId><ArticleId IdType="pubmed">20008565</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan J.R., Kolaitis R.-M., Taylor J.P., Parker R. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell. 2013;153:1461&#x2013;1474. doi: 10.1016/j.cell.2013.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.05.037</ArticleId><ArticleId IdType="pmc">PMC3760148</ArticleId><ArticleId IdType="pubmed">23791177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura Y., Fukushi J., Hori S., Matsuda N., Okatsu K., Kakiyama Y., Kawawaki J., Kakizuka A., Tanaka K. Different dynamic movements of wild-type and pathogenic VCP s and their cofactors to damaged mitochondria in a P arkin-mediated mitochondrial quality control system. Genes Cells. 2013;18:1131&#x2013;1143. doi: 10.1111/gtc.12103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12103</ArticleId><ArticleId IdType="pubmed">24215292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N.C., Tresse E., Kolaitis R.-M., Molliex A., Thomas R.E., Alami N.H., Wang B., Joshi A., Smith R.B., Ritson G.P. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron. 2013;78:65&#x2013;80. doi: 10.1016/j.neuron.2013.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.029</ArticleId><ArticleId IdType="pmc">PMC3683300</ArticleId><ArticleId IdType="pubmed">23498974</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaacs A.M., Johannsen P., Holm I., Nielsen J.E. Frontotemporal dementia caused by CHMP2B mutations. Curr. Alzheimer Res. 2011;8:246&#x2013;251. doi: 10.2174/156720511795563764.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720511795563764</ArticleId><ArticleId IdType="pmc">PMC3182073</ArticleId><ArticleId IdType="pubmed">21222599</ArticleId></ArticleIdList></Reference><Reference><Citation>Urwin H., Ghazi-Noori S., Collinge J., Isaacs A. The role of CHMP2B in frontotemporal dementia. Biochem. Soc. Trans. 2009;37:208&#x2013;212. doi: 10.1042/BST0370208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0370208</ArticleId><ArticleId IdType="pubmed">19143633</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusten T.E., Filimonenko M., Rodahl L.M., Stenmark H., Simonsen A. ESCRTing autophagic clearance of aggregating proteins. Autophagy. 2008;4:233&#x2013;236. doi: 10.4161/auto.5396.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S., Otomo A., Kunita R., Suzuki-Utsunomiya K., Akatsuka A., Koike M., Aoki M., Uchiyama Y., Itoyama Y., Ikeda J.-E. Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1H46R-expressing mouse ALS model by disturbing endolysosomal trafficking. PLoS ONE. 2010;5:e9805. doi: 10.1371/journal.pone.0009805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009805</ArticleId><ArticleId IdType="pmc">PMC2842444</ArticleId><ArticleId IdType="pubmed">20339559</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow C.Y., Landers J.E., Bergren S.K., Sapp P.C., Grant A.E., Jones J.M., Everett L., Lenk G.M., McKenna-Yasek D.M., Weisman L.S. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am. J. Hum. Genet. 2009;84:85&#x2013;88. doi: 10.1016/j.ajhg.2008.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.12.010</ArticleId><ArticleId IdType="pmc">PMC2668033</ArticleId><ArticleId IdType="pubmed">19118816</ArticleId></ArticleIdList></Reference><Reference><Citation>Rademakers R., van Blitterswijk M. Excess of rare damaging TUBA4A variants suggests cytoskeletal defects in ALS. Neuron. 2014;84:241&#x2013;243. doi: 10.1016/j.neuron.2014.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.10.002</ArticleId><ArticleId IdType="pubmed">25374348</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyttinen J.M., Niittykoski M., Salminen A., Kaarniranta K. Maturation of autophagosomes and endosomes: A key role for Rab7. Biochim. Biophys. Acta Mol. Cell Res. 2013;1833:503&#x2013;510. doi: 10.1016/j.bbamcr.2012.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2012.11.018</ArticleId><ArticleId IdType="pubmed">23220125</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Liao Q., Lu K., Zhou J., Huang C., Bi F. Riluzole exhibits no therapeutic efficacy on a transgenic rat model of amyotrophic lateral sclerosis. Curr. Neurovasc. Res. 2020;17:275&#x2013;285. doi: 10.2174/1567202617666200409125227.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567202617666200409125227</ArticleId><ArticleId IdType="pubmed">32271694</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedergaard M., Rodr&#xed;guez J.J., Verkhratsky A. Glial calcium and diseases of the nervous system. Cell Calcium. 2010;47:140&#x2013;149. doi: 10.1016/j.ceca.2009.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2009.11.010</ArticleId><ArticleId IdType="pubmed">20045186</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Aoki M., Tsuji S., Itoyama Y., Sobue G., Togo M., Hamada C., Tanaka M., Akimoto M., Nakamura K. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti O., Blomgren K., Poletti A., Beart P.M. Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases. J. Neurochem. 2020;154:354&#x2013;371. doi: 10.1111/jnc.15002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15002</ArticleId><ArticleId IdType="pubmed">32149395</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamadeh M.J., Rodriguez M.C., Kaczor J.J., Tarnopolsky M.A. Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse. Muscle Nerve. 2005;31:214&#x2013;220. doi: 10.1002/mus.20255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20255</ArticleId><ArticleId IdType="pubmed">15625688</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamadeh M.J., Tarnopolsky M.A. Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-SOD mutant G93A mice. Muscle Nerve. 2006;34:709&#x2013;719. doi: 10.1002/mus.20630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20630</ArticleId><ArticleId IdType="pubmed">16941656</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya A., Bokov A., Muller F.L., Jernigan A.L., Maslin K., Diaz V., Richardson A., Van Remmen H. Dietary restriction but not rapamycin extends disease onset and survival of the H46R/H48Q mouse model of ALS. Neurobiol. Aging. 2012;33:1829&#x2013;1832. doi: 10.1016/j.neurobiolaging.2011.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.06.002</ArticleId><ArticleId IdType="pubmed">21763036</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A., Majumder S., Deng J.J., Bai Y., Thornton F.B., Oddo S. Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J. Biol. Chem. 2009;284:27416&#x2013;27424. doi: 10.1074/jbc.M109.031278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.031278</ArticleId><ArticleId IdType="pmc">PMC2785671</ArticleId><ArticleId IdType="pubmed">19651785</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I.-F., Guo B.-S., Liu Y.-C., Wu C.-C., Yang C.-H., Tsai K.-J., Shen C.-K.J. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl. Acad. Sci. USA. 2012;109:15024&#x2013;15029. doi: 10.1073/pnas.1206362109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206362109</ArticleId><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Li L., Chen S., Yang D., Wang Y., Zhang X., Wang Z., Le W. Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Autophagy. 2011;7:412&#x2013;425. doi: 10.4161/auto.7.4.14541.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.4.14541</ArticleId><ArticleId IdType="pubmed">21193837</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats K.A., Hernandez S., Sch&#xf6;nefeldt S., Bento-Abreu A., Dooley J., Van Damme P., Liston A., Robberecht W., Van Den Bosch L. Rapamycin increases survival in ALS mice lacking mature lymphocytes. Mol. Neurodegener. 2013;8:31. doi: 10.1186/1750-1326-8-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-31</ArticleId><ArticleId IdType="pmc">PMC3847677</ArticleId><ArticleId IdType="pubmed">24025516</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo K., Nassif M., Valenzuela V., Rojas F., Matus S., Mercado G., Court F.A., van Zundert B., Hetz C. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy. 2013;9:1308&#x2013;1320. doi: 10.4161/auto.25188.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.25188</ArticleId><ArticleId IdType="pubmed">23851366</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Guo Y., Wang X., Yu X., Duan W., Hong K., Wang J., Han H., Li C. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Neuroscience. 2015;298:12&#x2013;25. doi: 10.1016/j.neuroscience.2015.03.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.03.061</ArticleId><ArticleId IdType="pubmed">25841320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Chen S., Song L., Tang Y., Shen Y., Jia L., Le W. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy. 2014;10:588&#x2013;602. doi: 10.4161/auto.27710.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.27710</ArticleId><ArticleId IdType="pmc">PMC4091147</ArticleId><ArticleId IdType="pubmed">24441414</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Escrevente C., Costa J. Mutant superoxide dismutase 1 overexpression in NSC-34 cells: Effect of trehalose on aggregation, TDP-43 localization and levels of co-expressed glycoproteins. Neurosci. Lett. 2010;475:145&#x2013;149. doi: 10.1016/j.neulet.2010.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2010.03.065</ArticleId><ArticleId IdType="pubmed">20363292</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R., Del Valle J., Modol L., Martinez A., Granado-Serrano A.B., Ramirez-N&#xfa;&#xf1;ez O., Pall&#xe1;s M., Portero-Otin M., Osta R., Navarro X. Resveratrol improves motoneuron function and extends survival in SOD1 G93A ALS mice. Neurotherapeutics. 2014;11:419&#x2013;432. doi: 10.1007/s13311-013-0253-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-013-0253-y</ArticleId><ArticleId IdType="pmc">PMC3996124</ArticleId><ArticleId IdType="pubmed">24414863</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S., Choi J.-R., Shin K.S., Kang S.J. Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice. Brain Res. 2012;1483:112&#x2013;117. doi: 10.1016/j.brainres.2012.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.09.022</ArticleId><ArticleId IdType="pubmed">23000195</ArticleId></ArticleIdList></Reference><Reference><Citation>Markert C.D., Kim E., Gifondorwa D.J., Childers M.K., Milligan C.E. A single-dose resveratrol treatment in a mouse model of amyotrophic lateral sclerosis. J. Med. Food. 2010;13:1081&#x2013;1085. doi: 10.1089/jmf.2009.0243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2009.0243</ArticleId><ArticleId IdType="pubmed">20626250</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Zhang Y., Tang L., Zhang N., Fan D. Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis. Neurosci. Lett. 2011;503:250&#x2013;255. doi: 10.1016/j.neulet.2011.08.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2011.08.047</ArticleId><ArticleId IdType="pubmed">21896316</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L., Chen L., Zhang X., Li J., Le W. Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1G93A mouse model of amyotrophic lateral sclerosis. BioMed Res. Int. 2014;2014 doi: 10.1155/2014/483501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/483501</ArticleId><ArticleId IdType="pmc">PMC4095711</ArticleId><ArticleId IdType="pubmed">25057490</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneb H.M., Sharp P.S., Rahmani-Kondori N., Wells D.J. Metformin treatment has no beneficial effect in a dose-response survival study in the sod1g93a mouse model of ALS and is harmful in female mice. PLoS ONE. 2011;6:e24189. doi: 10.1371/journal.pone.0024189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0024189</ArticleId><ArticleId IdType="pmc">PMC3164704</ArticleId><ArticleId IdType="pubmed">21909419</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Dong H., Liu Y., Yan L., Sun C., Hao P., Liu Y., Zhai J., Liu Y. Raloxifene, a promising estrogen replacement, limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis. Brain Res. Bull. 2018;140:281&#x2013;290. doi: 10.1016/j.brainresbull.2018.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.05.017</ArticleId><ArticleId IdType="pubmed">29807145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Kim T.-Y., Cho K.-S., Kim H.N., Koh J.-Y. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;59:80&#x2013;85. doi: 10.1016/j.nbd.2013.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.07.011</ArticleId><ArticleId IdType="pubmed">23891729</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura K., Izumi Y., Watanabe A., Tsukita K., Woltjen K., Yamamoto T., Hotta A., Kondo T., Kitaoka S., Ohta A. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci. Transl. Med. 2017;9:eaaf3962. doi: 10.1126/scitranslmed.aaf3962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf3962</ArticleId><ArticleId IdType="pubmed">28539470</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsumata R., Ishigaki S., Katsuno M., Kawai K., Sone J., Huang Z., Adachi H., Tanaka F., Urano F., Sobue G. c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e46185. doi: 10.1371/journal.pone.0046185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046185</ArticleId><ArticleId IdType="pmc">PMC3458026</ArticleId><ArticleId IdType="pubmed">23049975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornai F., Longone P., Cafaro L., Kastsiuchenka O., Ferrucci M., Manca M.L., Lazzeri G., Spalloni A., Bellio N., Lenzi P. Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2008;105:2052&#x2013;2057. doi: 10.1073/pnas.0708022105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0708022105</ArticleId><ArticleId IdType="pmc">PMC2538879</ArticleId><ArticleId IdType="pubmed">18250315</ArticleId></ArticleIdList></Reference><Reference><Citation>Group U.-L.S. Lithium in patients with amyotrophic lateral sclerosis (LiCALS): A phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2013;12:339&#x2013;345. doi: 10.1016/S1474-4422(13)70037-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70037-1</ArticleId><ArticleId IdType="pmc">PMC3610091</ArticleId><ArticleId IdType="pubmed">23453347</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal S.P., Zinman L., Simpson E., McKinley J., Jackson K.E., Pinto H., Kaufman P., Conwit R.A., Schoenfeld D., Shefner J. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9:481&#x2013;488. doi: 10.1016/S1474-4422(10)70068-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70068-5</ArticleId><ArticleId IdType="pmc">PMC3071495</ArticleId><ArticleId IdType="pubmed">20363190</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J.H., Cho S.I., Lim H.R., Lee J.K., Lee Y.A., Noh J.S., Joo I.S., Kim K.-W., Gwag B.J. Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis. Mol. Pharmacol. 2007;71:965&#x2013;975. doi: 10.1124/mol.106.030676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.106.030676</ArticleId><ArticleId IdType="pubmed">17105868</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Borghero G., Calvo A., Capasso M., Caponnetto C., Corbo M., Giannini F., Logroscino G., Mandrioli J., Marcello N. Lithium carbonate in amyotrophic lateral sclerosis: Lack of efficacy in a dose-finding trial. Neurology. 2010;75:619&#x2013;625. doi: 10.1212/WNL.0b013e3181ed9e7c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ed9e7c</ArticleId><ArticleId IdType="pubmed">20702794</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E., Veldink J.H., Huisman M.H., Draak T., Uijtendaal E.V., van der Kooi A.J., Schelhaas H.J., de Visser M., van der Tweel I., van den Berg L.H. Lithium lacks effect on survival in amyotrophic lateral sclerosis: A phase IIb randomised sequential trial. J. Neurol. Neurosurg. Psychiatry. 2012;83:557&#x2013;564. doi: 10.1136/jnnp-2011-302021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-302021</ArticleId><ArticleId IdType="pubmed">22378918</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R., Moore D., Forshew D., Katz J., Barohn R., Valan M., Bromberg M., Goslin K., Graves M., McCluskey L. Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: Examining a more efficient trial design. Neurology. 2011;77:973&#x2013;979. doi: 10.1212/WNL.0b013e31822dc7a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31822dc7a5</ArticleId><ArticleId IdType="pmc">PMC3171956</ArticleId><ArticleId IdType="pubmed">21813790</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugai F., Yamamoto Y., Miyaguchi K., Zhou Z., Sumi H., Hamasaki T., Goto M., Sakoda S. Benefit of valproic acid in suppressing disease progression of ALS model mice. Eur. J. Neurosci. 2004;20:3179&#x2013;3183. doi: 10.1111/j.1460-9568.2004.03765.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2004.03765.x</ArticleId><ArticleId IdType="pubmed">15579172</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Ma M., Teng J., Che X., Zhang W., Feng S., Zhou S., Zhang Y., Wu E., Ding X. Valproate attenuates 25-kDa C-terminal fragment of TDP-43-induced neuronal toxicity via suppressing endoplasmic reticulum stress and activating autophagy. Int. J. Biol. Sci. 2015;11:752&#x2013;761. doi: 10.7150/ijbs.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.11880</ArticleId><ArticleId IdType="pmc">PMC4466456</ArticleId><ArticleId IdType="pubmed">26078717</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouaux C., Panteleeva I., Ren&#xe9; F., de Aguilar J.-L.G., Echaniz-Laguna A., Dupuis L., Menger Y., Boutillier A.-L., Loeffler J.-P. Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J. Neurosci. 2007;27:5535&#x2013;5545. doi: 10.1523/JNEUROSCI.1139-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1139-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672753</ArticleId><ArticleId IdType="pubmed">17522299</ArticleId></ArticleIdList></Reference><Reference><Citation>Piepers S., Veldink J.H., De Jong S.W., Van Der Tweel I., Van Der Pol W.L., Uijtendaal E.V., Schelhaas H.J., Scheffer H., De Visser M., De Jong J.V. Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis. Ann. Neurol. 2009;66:227&#x2013;234. doi: 10.1002/ana.21620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21620</ArticleId><ArticleId IdType="pubmed">19743466</ArticleId></ArticleIdList></Reference><Reference><Citation>Boll M.-C., Bayliss L., Vargas-Ca&#xf1;as S., Burgos J., Montes S., Pe&#xf1;aloza-Solano G., Rios C., Alcaraz-Zubeldia M. Clinical and biological changes under treatment with lithium carbonate and valproic acid in sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 2014;340:103&#x2013;108. doi: 10.1016/j.jns.2014.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.03.005</ArticleId><ArticleId IdType="pubmed">24667005</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H.-L., Leng Y., Ma C.-H., Zhang J., Ren M., Chuang D.-M. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience. 2008;155:567&#x2013;572. doi: 10.1016/j.neuroscience.2008.06.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2008.06.040</ArticleId><ArticleId IdType="pmc">PMC2709275</ArticleId><ArticleId IdType="pubmed">18640245</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Serio A., Arjun A., Bilican B., Daub A., Ando D.M., Tsvetkov A., Pleiss M., Li X., Peisach D. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 2014;10:677&#x2013;685. doi: 10.1038/nchembio.1563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1563</ArticleId><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi S., Thammisetty S.S., Julien J.-P. Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2018;15:715&#x2013;727. doi: 10.1007/s13311-018-0634-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-018-0634-3</ArticleId><ArticleId IdType="pmc">PMC6095790</ArticleId><ArticleId IdType="pubmed">29790082</ArticleId></ArticleIdList></Reference><Reference><Citation>Szczudlik A., Tomik B., S&#x142;owik A., Kasprzyk K. Assessment of the efficacy of treatment with pimozide in patients with amyotrophic lateral sclerosis. Introductory notes. Neurol. Neurochir. Pol. 1998;32:821&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pubmed">9864711</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R., Smith S., Murphy J., Brinkamann J.R., Graves J., Mendoza M., Sands M., Ringel S. A clinical trial of verapamil in amyotrophic lateral sclerosis. Muscle Nerve. 1996;19:511&#x2013;515. doi: 10.1002/mus.880190405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880190405</ArticleId><ArticleId IdType="pubmed">8622731</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera N.D., Sheean R.K., Lau C.L., Shin Y.S., Beart P.M., Horne M.K., Turner B.J. Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression. Autophagy. 2018;14:534&#x2013;551. doi: 10.1080/15548627.2017.1385674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1385674</ArticleId><ArticleId IdType="pmc">PMC5915012</ArticleId><ArticleId IdType="pubmed">28980850</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.-F., Lee Y.-C., Lee K.-H., Lin H.-C., Chen C.-L., Shen C.-K.J., Huang C.-C. Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. J. Biomed. Sci. 2016;23:72&#x2013;84. doi: 10.1186/s12929-016-0290-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-016-0290-z</ArticleId><ArticleId IdType="pmc">PMC5073438</ArticleId><ArticleId IdType="pubmed">27769241</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan K.S., Mitchem M.R., Hogg M.C., Prehn J.H. &#x201c;Preconditioning&#x201d; with latrepirdine, an adenosine 5&#x2032;-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1G93A mice. Neurobiol. Aging. 2015;36:1140&#x2013;1150. doi: 10.1016/j.neurobiolaging.2014.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.09.022</ArticleId><ArticleId IdType="pubmed">25443289</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Fabbrizio P., Parisi C., Amadio S., Volont&#xe9; C. Clemastine confers neuroprotection and induces an anti-inflammatory phenotype in SOD1 G93A mouse model of amyotrophic lateral sclerosis. Mol. Neurobiol. 2016;53:518&#x2013;531. doi: 10.1007/s12035-014-9019-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-9019-8</ArticleId><ArticleId IdType="pubmed">25482048</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Fabbrizio P., Amadio S., Volont&#xe9; C. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression. J. Neuroinflamm. 2016;13:191&#x2013;206. doi: 10.1186/s12974-016-0658-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0658-8</ArticleId><ArticleId IdType="pmc">PMC4994328</ArticleId><ArticleId IdType="pubmed">27549088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature. 2008;451:1069&#x2013;1075. doi: 10.1038/nature06639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06639</ArticleId><ArticleId IdType="pmc">PMC2670399</ArticleId><ArticleId IdType="pubmed">18305538</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B., Klionsky D.J. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev. Cell. 2004;6:463&#x2013;477. doi: 10.1016/S1534-5807(04)00099-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1534-5807(04)00099-1</ArticleId><ArticleId IdType="pubmed">15068787</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney D.J., Rodriguez C., Devries M., Yasuda N., Tarnopolsky M.A. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2004;29:656&#x2013;662. doi: 10.1002/mus.20004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20004</ArticleId><ArticleId IdType="pubmed">15116368</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N., Yamamoto A., Matsui M., Yoshimori T., Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell. 2004;15:1101&#x2013;1111. doi: 10.1091/mbc.e03-09-0704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e03-09-0704</ArticleId><ArticleId IdType="pmc">PMC363084</ArticleId><ArticleId IdType="pubmed">14699058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravikumar B., Duden R., Rubinsztein D.C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 2002;11:1107&#x2013;1117. doi: 10.1093/hmg/11.9.1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.9.1107</ArticleId><ArticleId IdType="pubmed">11978769</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger Z., Ravikumar B., Menzies F.M., Oroz L.G., Underwood B.R., Pangalos M.N., Schmitt I., Wullner U., Evert B.O., O&#x2019;kane C.J. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 2005;15:433&#x2013;442. doi: 10.1093/hmg/ddi458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi458</ArticleId><ArticleId IdType="pubmed">16368705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravikumar B., Vacher C., Berger Z., Davies J.E., Luo S., Oroz L.G., Scaravilli F., Easton D.F., Duden R., O&#x2019;Kane C.J. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004;36:585&#x2013;595. doi: 10.1038/ng1362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1362</ArticleId><ArticleId IdType="pubmed">15146184</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata A., Christianson J.C., Bucci M., Ellerby L.M., Nukina N., Forno L.S., Kopito R.R. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc. Natl. Acad. Sci. USA. 2005;102:13135&#x2013;13140. doi: 10.1073/pnas.0505801102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0505801102</ArticleId><ArticleId IdType="pmc">PMC1201602</ArticleId><ArticleId IdType="pubmed">16141322</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes K., Brown K., Hunger N., Simpson E. Regulation of LKB1 expression by sex hormones in adipocytes. Int. J. Obes. 2012;36:982&#x2013;985. doi: 10.1038/ijo.2011.172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2011.172</ArticleId><ArticleId IdType="pubmed">21876548</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J.P., Visser A.E., D&#x2019;ovidio F., Vermeulen R., Beghi E., Chio A., Veldink J.H., Logroscino G., van den Berg L.H., Hardiman O. A case-control study of hormonal exposures as etiologic factors for ALS in women: Euro-MOTOR. Neurology. 2017;89:1283&#x2013;1290. doi: 10.1212/WNL.0000000000004390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004390</ArticleId><ArticleId IdType="pubmed">28835399</ArticleId></ArticleIdList></Reference><Reference><Citation>Trieu V.N., Uckun F.M. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem. Biophys. Res. Commun. 1999;258:685&#x2013;688. doi: 10.1006/bbrc.1999.0577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1999.0577</ArticleId><ArticleId IdType="pubmed">10329446</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneveld G., Van Muiswinkel F., Sturkenboom J., Wokke J., B&#xe4;r P., Van den Berg L. Ovariectomy and 17&#x3b2;-estradiol modulate disease progression of a mouse model of ALS. Brain Res. 2004;1021:128&#x2013;131. doi: 10.1016/j.brainres.2004.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.06.024</ArticleId><ArticleId IdType="pubmed">15328040</ArticleId></ArticleIdList></Reference><Reference><Citation>Aktekin M.R., Uysal H. Epidemiology of Amyotrophic Lateral Sclerosis. Turk. Noroloji Dergisi. 2020;26:187&#x2013;196. doi: 10.4274/tnd.2020.45549.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/tnd.2020.45549</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S., Floto R.A., Berger Z., Imarisio S., Cordenier A., Pasco M., Cook L.J., Rubinsztein D.C. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 2005;170:1101&#x2013;1111. doi: 10.1083/jcb.200504035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200504035</ArticleId><ArticleId IdType="pmc">PMC2171537</ArticleId><ArticleId IdType="pubmed">16186256</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris H., Rubinsztein D.C. Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 2012;8:108&#x2013;117. doi: 10.1038/nrneurol.2011.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.200</ArticleId><ArticleId IdType="pubmed">22187000</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangan D. Autophagy activation as a mechanism of action of psychoactive drugs, revised and expanded version. Biol. Sci. 2015 doi: 10.15200/winn.143268.86120.</Citation><ArticleIdList><ArticleId IdType="doi">10.15200/winn.143268.86120</ArticleId></ArticleIdList></Reference><Reference><Citation>Bootman M.D., Chehab T., Bultynck G., Parys J.B., Rietdorf K. The regulation of autophagy by calcium signals: Do we have a consensus? Cell Calcium. 2018;70:32&#x2013;46. doi: 10.1016/j.ceca.2017.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2017.08.005</ArticleId><ArticleId IdType="pubmed">28847414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun F., Xu X., Wang X., Zhang B. Regulation of autophagy by Ca 2+ Tumour Biol. 2016;37:15467&#x2013;15476. doi: 10.1007/s13277-016-5353-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-016-5353-y</ArticleId><ArticleId IdType="pmc">PMC5250648</ArticleId><ArticleId IdType="pubmed">27864685</ArticleId></ArticleIdList></Reference><Reference><Citation>Baronio D., Gonchoroski T., Castro K., Zanatta G., Gottfried C., Riesgo R. Histaminergic system in brain disorders: Lessons from the translational approach and future perspectives. Ann. Gen. Psychiatry. 2014;13:34. doi: 10.1186/s12991-014-0034-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12991-014-0034-y</ArticleId><ArticleId IdType="pmc">PMC4243384</ArticleId><ArticleId IdType="pubmed">25426159</ArticleId></ArticleIdList></Reference><Reference><Citation>Thors B., Halld&#xf3;rsson H., Thorgeirsson G. eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1. Biochim. Biophys. Acta Mol. Cell Res. 2011;1813:322&#x2013;331. doi: 10.1016/j.bbamcr.2010.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2010.12.001</ArticleId><ArticleId IdType="pubmed">21145922</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisov&#xe1; P., Alvarez S., Kilbride S.M., Anilkumar U., Baumann B., Jord&#xe1;n J., Bernas T., Huber H.J., D&#xfc;ssmann H., Prehn J.H. Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability. Transl. Psychiatry. 2013;3:e317. doi: 10.1038/tp.2013.92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2013.92</ArticleId><ArticleId IdType="pmc">PMC3818013</ArticleId><ArticleId IdType="pubmed">24150226</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Sahra I., Manning B.D. mTORC1 signaling and the metabolic control of cell growth. Curr. Opin. Cell Biol. 2017;45:72&#x2013;82. doi: 10.1016/j.ceb.2017.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2017.02.012</ArticleId><ArticleId IdType="pmc">PMC5545101</ArticleId><ArticleId IdType="pubmed">28411448</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X.G., Liu F., Song X.F., Wang Z.H., Dong Z.Q., Hu Z.Q., Lan R.Z., Guan W., Zhou T.G., Xu X.M. Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathways. Mol. Carcinog. 2010;49:603&#x2013;610. doi: 10.1002/mc.20628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.20628</ArticleId><ArticleId IdType="pubmed">20512842</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Dibble C.C., Matsuzaki M., Manning B.D. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol. Cell Biol. 2008;28:4104&#x2013;4115. doi: 10.1128/MCB.00289-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00289-08</ArticleId><ArticleId IdType="pmc">PMC2423120</ArticleId><ArticleId IdType="pubmed">18411301</ArticleId></ArticleIdList></Reference><Reference><Citation>King M.A., Hands S., Hafiz F., Mizushima N., Tolkovsky A.M., Wyttenbach A. Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis. Mol. Pharmacol. 2008;73:1052&#x2013;1063. doi: 10.1124/mol.107.043398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.107.043398</ArticleId><ArticleId IdType="pubmed">18199701</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetkov A.S., Mitra S., Finkbeiner S. Protein turnover differences between neurons and other cells. Autophagy. 2009;5:1037&#x2013;1038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892253</ArticleId><ArticleId IdType="pubmed">19838079</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eijk R.P., Jones A.R., Sproviero W., Shatunov A., Shaw P.J., Leigh P.N., Young C.A., Shaw C.E., Mora G., Mandrioli J. Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials. Neurology. 2017;89:1915&#x2013;1922. doi: 10.1212/WNL.0000000000004606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004606</ArticleId><ArticleId IdType="pmc">PMC5664299</ArticleId><ArticleId IdType="pubmed">28978660</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zhou J., Xi M., Jia Y., Wong Y., Zhao J., Ding L., Zhang J., Wen A. Pharmacogenetic variation and metformin response. Curr. Drug Metab. 2013;14:1070&#x2013;1082. doi: 10.2174/1389200214666131211153933.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389200214666131211153933</ArticleId><ArticleId IdType="pubmed">24329113</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Leary V.B., Ovsepian S.V., Bodeker M., Dolly J.O. Improved lentiviral transduction of ALS motoneurons in vivo via dual targeting. Mol. Pharm. 2013;10:4195&#x2013;4206. doi: 10.1021/mp400247t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/mp400247t</ArticleId><ArticleId IdType="pubmed">24066863</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovsepian S.V., O&#x2019;Leary V.B., Ntziachristos V., Dolly J.O. Circumventing brain barriers: Nanovehicles for retroaxonal therapeutic delivery. Trends Mol. Med. 2016;22:983&#x2013;993. doi: 10.1016/j.molmed.2016.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.09.004</ArticleId><ArticleId IdType="pubmed">27720365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovespian S.V., Bodeker M., O&#x2019;Leary V.B., Lawrence G.W., Dolly J.O. Internalization and retrograde axonal trafficking of tetanus toxin in motor neurons and trans-synaptic propagation at central synapses exceed those of its C-terminal-binding fragments. Brain Struct. Funct. 2015;220:1825&#x2013;1838. doi: 10.1007/s00429-015-1004-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-015-1004-0</ArticleId><ArticleId IdType="pubmed">25665801</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>